News - details

7 May 2003

Isogenica signs an exclusive enabling agreement with Smiths Detection

Isogenica Ltd, Cambridge, UK today announced that it has signed an exclusive enabling agreement with Smiths Detection for the use of the company’s CIS display for the discovery of detection reagents for biological warfare agents.